Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects

Key Points

• The survivin-derived peptide disrupts survivin dimerization, leading to altered cell division.
• Significant anti-cancer effects are observed through this peptide, impacting tumor growth.
• Analysis utilized in vitro experimental approaches to assess the peptide's function on cancer cells.
• Supports further investigations into survivin-targeting therapies for cancer treatment.